Main Banners
  • Home
  • Agenda
  • Speakers
  • Companies
  • Sponsors
  • Yelp Guide
  • Blog/News
  • Session Feedback
  • Browse
  • Exhibit Hall Navigation
business_icon

Business Development and Finance

Get Relevant or Go Home: Shedding Light on Oncology R&D Sums

107AB, Level 100

Ms. Lisa UrquhartEditor, Vantage atEvaluate Ltd Curtis HechtChief Business Officer atCalithera Biosciences Dr. Paul JuniewiczSr. Director, Oncology Search & Evaluation atTakeda Debi WatsonVice President, Business Development and Licensing atJohnson & Johnson Innovation, Janssen Business Development
bio2018super_sessions

What’s Next: The Landscape of Innovation in 2019 and Beyond

103ABC, Level 100

Barbara DaltonVice President, Worldwide Business Development atPfizer Inc. Dr. David DonabedianCo-founder, CEO and Director atAxial Biotherapeutics Chris GarabedianChairman and CEO atXontogeny, LLC Curt HerbertsChief Financial Officer and Chief Business Officer atSenti Biosciences, Inc. David ThomasVice President, Industry Research atBiotechnology Innovation Organization Ben ThornerSenior Vice President & Head, MRL Business Development & Licensing atMerck & Co., Inc. Sam UlinManaging Director atClearView Healthcare Partners
oncologyicon

Oncology

What Was Hot at ASCO 2019? Highlights from the World’s Biggest Oncology Meeting

105AB, Level 100

Ted TentoffSr. Research Analyst atPiper Jaffray Sam AgrestaChief Medical Officer atInfinity Pharmaceuticals Roy BaynesSenior Vice President, Global Clinical Development & Chief Medical Officer atMerck Research Laboratories Howard "Skip" BurrisPresident atASCO Patricia KeeganDirector, Division of Oncology Products 2 atCenter for Drug Evaluation and Research (CDER), FDA Dr. Thomas LynchExecutive Vice President, Chief Scientific Officer atBristol-Myers Squibb
Powered by Eventsforce Copyright 2021. Privacy Support